Posted On: 05/11/2013 8:22:58 PM
Post# of 63884
OTCbb Friday Evening.
| Name | Symbol | Last Price | Chg | % Chg | Open | High | Low | Volume | Trade Val | # |
|---|
| Active Health Foods Inc. Common | AHFD | 0.0001 |  | -0.0002 | -66.67% | 0.0003 | 0.0003 | 0.0001 | 67.96 m | 10.66 k | 21 |
| Federal National Mortgage Association | FNMA | 0.881 |  | 0.007 | 0.80% | 0.8992 | 0.90 | 0.8492 | 16.86 m | 14.7 m | 2,635 |
| Innovative Product Opportunities Inc | IPRU | 0.0019 | | 0.0004 | 26.67% | 0.0018 | 0.0019 | 0.0015 | 14.69 m | 23.27 k | 34 |
| Solo International Inc. Common | SLIO | 0.01 | | 0.001 | 11.11% | 0.0122 | 0.0124 | 0.009 | 10.23 m | 103.89 k | 212 |
| Cord Blood America Inc. | CBAI | 0.0037 |  | 0.00 | 0.00% | 0.0037 | 0.0039 | 0.0035 | 9.62 m | 33.92 k | 39 |
| Federal Home Loan Mortgage Corporation | FMCC | 0.843 | | -0.002 | -0.24% | 0.857 | 0.87 | 0.82 | 9.12 m | 7.64 m | 1,317 |
| Goff Corp | GOFF | 0.0285 | | -0.001 | -3.39% | 0.0295 | 0.0329 | 0.027 | 7.53 m | 219.34 k | 287 |
| African Copper Corporation | ACCS | 0.15 | | 0.001 | 0.67% | 0.155 | 0.247 | 0.137 | 7.21 m | 1.37 m | 846 |
| Alternative Energy Partners Inc. | AEGY | 0.0008 | | 0.0003 | 60.00% | 0.0005 | 0.0008 | 0.0005 | 6.74 m | 4.71 k | 27 |
| iTalk Inc. | TALK | 1.75 | | 0.19 | 12.18% | 1.60 | 1.76 | 1.60 | 6.11 m | 10.19 m | 2,028 |
| 05/10/13 11:12 PM EDT | CommerceWest Bank Sponsored the United Cerebral Palsy Life Without Limits Gala - Business Wire |
| 05/10/13 5:32 PM EDT | SPY Inc. Announces Investor Conference Call for the Quarter Ended March 31, 2013 - Marketwired |
| 05/10/13 5:25 PM EDT | Galaxy Gaming to Announce First Quarter 2013 Financial Results Teleconference and Webcast - Globe Newswire |
| 05/10/13 5:15 PM EDT | Jagged Peak Announces Financial Results for the First Quarter of 2013 - Globe Newswire |
| 05/10/13 5:03 PM EDT | FEEL Golf Co., Inc. Acquires Israeli On-Line Brain Training Games Company, Mind360 - PR Newswire |
| 05/10/13 4:36 PM EDT | Third Party Presented New Data at the ARVO 2013 Annual Meeting in Seattle, WA, Validating the use of A3 Adenosine Receptor Agonists for Lowering Intra Ocular Pressure and for the Treatment of Glaucoma - PR Newswire |
| 05/10/13 4:26 PM EDT | Greate |
(0)
(0)
